High-risk adverse events in two types of single inhaler triple-therapy: a pharmacovigilance study based on the FAERS database
Our study provides a preliminary exploration of the safety of clinical use of BUD/GLY/FOR and FF/UMEC/VI, and clinicians should be alert to potential adverse effects.
Authors
- Yiling Fan
- Bo Xu (ORCID: https://orcid.org/0000-0003-0594-9103)
- Chunbin Wang (ORCID: https://orcid.org/0000-0002-3299-130X)
- Zhishen Ruan
- Shasha Yuan
- Dan Li (ORCID: https://orcid.org/0000-0003-2242-9169)
- Xiaodong Cong
- Qing Miao (ORCID: https://orcid.org/0000-0003-2478-9846)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Shandong Provincial Hospital (CN)
- Xiyuan Hospital (CN)
- Shuguang Hospital (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2025-01-09
- DOI
- https://doi.org/10.3389/fphar.2024.1460407
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- National Natural Science Foundation of China
- China Academy of Chinese Medical Sciences